It was recently reported by Iglewski and Rittenberg in THESE PROCEEDINGS (71,(2707)(2708)(2709)(2710) 1974 (5, 6) or in cell culture (6). Indeed, Iglewski and Rittenberg (6) have claimed that protein synthesis in Ehrlich-Lettre (E-La) cells is at least 10,000 times more sensitive to inhibition by toxin than is protein synthesis in normal mouse cells. Largely, based on this finding, they have proposed that diphtheria toxin may prove a useful anti-cancer agent for human patients.
us nor could the authors' further claim that toxin can cause regression of well-established ascites tumors in preimmunized mice be confirmed. Although temporary regression of such tumors can be demonstrated in unimmunized mice following intraperitoneal injection of diphtheria toxin, the amounts of toxin required are high and approach the lethal dose. About the same amount of CRM45, a tox gene product serologically related to diphtheria toxin but only 1/10,000th as toxic for guinea pigs, will also cause temporary regression in tumor-bearing mice. Since the discovery of diphtheria toxin more than 90 years ago, it has been known that mice and rats are exceptionally resistant to its lethal action (1) . Similarly, cultured cells of mouse origin, such as L-cells, are unaffected by toxin concentrations several thousand times greater than are required to inhibit protein synthesis in cells from sensitive species (2) (3) (4) . Recently, there have been reports that mouse Ehrlich ascites tumor cells carried in Swiss mice are more sensitive to the action of diphtheria toxin than are normal mouse cells either when tested in vivo (5, 6) or in cell culture (6) . Indeed, Iglewski and Rittenberg (6) have claimed that protein synthesis in Ehrlich-Lettre (E-La) cells is at least 10,000 times more sensitive to inhibition by toxin than is protein synthesis in normal mouse cells. Largely, based on this finding, they have proposed that diphtheria toxin may prove a useful anti-cancer agent for human patients.
In the present paper we report our failure to confirm the experiments of Iglewski and Rittenberg (6) . We will show that the apparent effect of toxin on E-La cells which they observed in vitro, can be explained most simply by their failure to supply factor(s) present in undialysed fetal calf serum that are needed for the maintenance of protein synthesis in these tumor cells.
While it appears to be true that diphtheria toxin can cause a striking, albeit temporary, regression of established Ehrlich ascites tumors, the doses required are large and very close to those that are lethal for mice. From our observations it seems unlikely that diphtheria toxin could be used effectively as a safe anti-cancer agent either in mice or in humans. When a 3-5 hour pulse with 14C-labeled amino-acid mixture was carried out in the absence of toxin using the modified medium described by Iglewski and Rittenberg (i.e., 1% the usual amino-acid concentrations except for glutamine, and 2% dialysed FCS) we found that incorporation of label into E-La cell protein was only about 20-25% of the uptake observed during the first 2 hr. Iglewski and Rittenberg (6) reported that incorporation of labeled amino acids during a 3-5 hr pulse was about 20% of the "control" value at all concentrations of toxin which they tested covering a 20,000-fold range from 0.003 to 60 ,g/ml. They apparently did not test the effect of toxin concentrations below 0.003 ug/ml. Effect of toxin and related proteins on established ascites tumors Groups of four to six Swiss mice were injected intraperitoneally (i.p.) on day zero with E-La cells and 5 days later with diphtheria toxin. This is the same schedule described by Iglewski and Rittenberg (6) . In other experiments, tumorbearing mice were treated with CRM45 or with purified fragment A. It will be recalled that CRM45, the product of a mutant tox gene which lacks the 17,000 dalton C-terminal amino-acid sequence of toxin, is less than 1/10,000th as toxic for guinea pigs as toxin itself (11) . Its A fragment is normal and has the same ADP-ribosylating activity on EF2 as fragment A isolated from toxin (11) . Mice were weighed daily. About 3-4 days after injection of about 107 E-La cells, tumor-bearing mice began to gain weight at a high rate compared to uninjected control mice. In Fig. 3 , the average weight gain of each group is expressed as percent of that group's average weight on day zero. A decline in rate of weight gain was taken to indicate tumor regression. Fig. 3 shows that according to this criterion, a single dose of 2.5 ,g or more of either toxin itself or of CRM45 
MATERIALS AND METHODS

DISCUSSION
The present studies clearly show that fetal calf serum contains a factor which is necessary for growth of freshly isolated Ehrlich ascites tumor cells (Lettre strain). The factor is not required by the S3 strain of HeLa cells. This is not a novel observation since the importance of serum factors in the cultivation of animal cells has been demonstrated repeatedly (12) . We find that although amino-acid incorporation into protein by washed suspensions of E-La cells in MEM supplemented with undialysed FCS will continue at an undiminished rate for many hours, incorporation ceases after 2-3 hr when 2% dialysed FCS is used as a supplement.
It is obvious that under such conditions, incorporation of a labeled amino-acid mixture into protein during a 3-5 hr pulse has very little meaning and cannot be used to measure sensitivity to a bacterial toxin as claimed by Iglewski and Rittenberg (6) . As shown in Fig. 1 , even high concentrations of toxin have no effect on protein synthesis by E-La cells over a 6 hr period in the presence of undialysed FCS.
The relatively high resistance of mice and rats and of cultured cells from these species to diphtheria toxin is apparently due to a lack of membrane receptors specific for the toxin B-polypeptide chain (fragment B). Although mice are several thousand times more resistant to the lethal action of diphtheria toxin as are guinea pigs or humans, they do develop paralysis and die after receiving doses of 3 /ig or more. With such high doses, enough toxin probably becomes internalized by a nonspecific'endocytotic mechanism. Probably, a few molecules of the relatively resistant A-fragment manage to escape degradation by lysosomal enzymes and reach the cytoplasm to block protein synthesis in a sufficient number of cells to cause death of the animal. Such a nonspecific endocytotic mechanism of entry would explain why CRM45 is just as toxic for mice and just as effective in causing regression of mouse ascites tumors as is toxin itself. Yet CRM45 is less than 1/10,000th as toxic as intact toxin when injected into guinea pigs. Ascites cells are actively pinocytotic. It may well'be that the increased sensitivity to toxic proteins reported for ascites tumor cells and even solid tumors may be attributed to their high pinocytotic activity and to the fact that the toxin is injected directly into the tumor. Such a mechanism would also explain the results of Buzzi (19) , preparations of such low specific toxicity almost certainly contained degraded toxin which nonetheless still flocculated with antitoxin. Such degraded material would be expected to behave similar to CRM's such as CRM45.
In conclusion, we can find no convincing evidence, either from our own experiments or those of others, that Ehrlich ascites tumor cells are any more sensitive to the action of diphtheria toxin than are the cells of normal mice. Any suggestion that diphtheria toxin may prove to be a useful agent in the treatment of human cancer would appear to be premature at this time.
